FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

449043000: Belimumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2011. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2897672010 Belimumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2902019015 Belimumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Belimumab Is a Substance with immunomodulator mechanism of action true Inferred relationship Existential restriction modifier
Belimumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Belimumab Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Belimumab Is a Immunologic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely belimumab 400 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has active ingredient False Belimumab Inferred relationship Existential restriction modifier
Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has active ingredient False Belimumab Inferred relationship Existential restriction modifier
Product containing belimumab Has active ingredient True Belimumab Inferred relationship Existential restriction modifier 1
Product containing belimumab in parenteral dose form (medicinal product form) Has active ingredient True Belimumab Inferred relationship Existential restriction modifier 1
Belimumab therapy Direct substance True Belimumab Inferred relationship Existential restriction modifier 2
Belimumab Has active ingredient True Belimumab Inferred relationship Existential restriction modifier 1
Product containing only belimumab in parenteral dose form (medicinal product form) Has active ingredient True Belimumab Inferred relationship Existential restriction modifier 1
Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has basis of strength substance False Belimumab Inferred relationship Existential restriction modifier 1
Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has precise active ingredient False Belimumab Inferred relationship Existential restriction modifier 1
Product containing precisely belimumab 400 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has precise active ingredient False Belimumab Inferred relationship Existential restriction modifier 1
Product containing precisely belimumab 400 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has basis of strength substance False Belimumab Inferred relationship Existential restriction modifier 1
Product containing precisely belimumab 120 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Belimumab Inferred relationship Existential restriction modifier 1
Product containing precisely belimumab 120 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Belimumab Inferred relationship Existential restriction modifier 1
Product containing precisely belimumab 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Belimumab Inferred relationship Existential restriction modifier 1
Product containing precisely belimumab 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Belimumab Inferred relationship Existential restriction modifier 1
Belimumab 400mg powder for solution for infusion vials Has active ingredient False Belimumab Inferred relationship Existential restriction modifier
Belimumab 200mg/1ml solution for injection pre-filled disposable devices 4 pre-filled disposable injection Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) 4 pre-filled disposable injection Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Belimumab 120mg powder for solution for infusion vials Has active ingredient False Belimumab Inferred relationship Existential restriction modifier
Belimumab 200mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Belimumab 200mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Benlysta 200mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Belimumab 120mg powder for solution for infusion vials Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Belimumab 400mg powder for solution for infusion vials Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Benlysta 120mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Belimumab 120mg powder for solution for infusion vials 1 vial Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Belimumab 400mg powder for solution for infusion vials 1 vial Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier
Benlysta 120mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial Has specific active ingredient True Belimumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start